Intracellular interleukin-1 receptor antagonist in osteoarthritis chondrocytes

Minako Murata, Carol Trahan, Junichi Hirahashi, Henry J. Mankin, Christine A. Towle

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The objective of the current study was to determine whether the balance of interleukin-1 and intracellular interleukin-1 receptor antagonist in chondrocytes in osteoarthritic human joints favors agonist action. Chondrocytes were isolated from cartilage specimens taken at the time of joint arthroplasty. Interleukin-1α, interleukin-1β, and intracellular interleukin-1 receptor antagonist messenger ribonucleic acids were assessed by reverse transcriptase-polymerase chain reaction, and chondrocyte lysates were analyzed by enzyme-linked immunosorbent assay for the respective proteins. Type I intracellular interleukin receptor antagonist transcripts were the only intracellular variant detected in osteoarthritis chondrocytes. In cartilage graded as advanced osteoarthritis both interleukin proteins in chondrocyte lysates decreased, correlating with decreased interleukin-1α and β messenger ribonucleic acids. Interleukin-1 receptor antagonist exceeded interleukin-1α in chondrocyte lysates by one order of magnitude except that in moderate osteoarthritis, antagonist was only two- to fourfold in excess. Interleukin-1α and interleukin-1β proteins were correlated closely in individual lysates, with interleukin-1β exceeding interleukin-1β by one order of magnitude. In moderately degenerated cartilage, intracellular antagonist may not be sufficiently abundant to block postulated intracellular functions of precursor interleukin-1α. Furthermore, if stored interleukin-1α, interleukin-1β, and interleukin receptor antagonist are released from chondrocytes, the localized antagonist would be insufficient to prevent signaling through cell surface receptors. Chondrocyte-derived interleukin-1α and interleukin-1β may locally overwhelm inhibition by interleukin receptor antagonist to promote the early degenerative changes in osteoarthritis.

Original languageEnglish
Pages (from-to)285-295
Number of pages11
JournalClinical Orthopaedics and Related Research
Issue number409
Publication statusPublished - 2003 Apr 1
Externally publishedYes

Fingerprint

Interleukin-1 Receptors
Chondrocytes
Interleukin-1
Osteoarthritis
Interleukin Receptors
Cartilage
Joints
RNA
Proteins
Interleukins
Cell Surface Receptors
Reverse Transcriptase Polymerase Chain Reaction
Arthroplasty
Enzyme-Linked Immunosorbent Assay

ASJC Scopus subject areas

  • Surgery
  • Orthopedics and Sports Medicine

Cite this

Intracellular interleukin-1 receptor antagonist in osteoarthritis chondrocytes. / Murata, Minako; Trahan, Carol; Hirahashi, Junichi; Mankin, Henry J.; Towle, Christine A.

In: Clinical Orthopaedics and Related Research, No. 409, 01.04.2003, p. 285-295.

Research output: Contribution to journalArticle

Murata, Minako ; Trahan, Carol ; Hirahashi, Junichi ; Mankin, Henry J. ; Towle, Christine A. / Intracellular interleukin-1 receptor antagonist in osteoarthritis chondrocytes. In: Clinical Orthopaedics and Related Research. 2003 ; No. 409. pp. 285-295.
@article{871e83b7aa5d444f8047e38b30e69905,
title = "Intracellular interleukin-1 receptor antagonist in osteoarthritis chondrocytes",
abstract = "The objective of the current study was to determine whether the balance of interleukin-1 and intracellular interleukin-1 receptor antagonist in chondrocytes in osteoarthritic human joints favors agonist action. Chondrocytes were isolated from cartilage specimens taken at the time of joint arthroplasty. Interleukin-1α, interleukin-1β, and intracellular interleukin-1 receptor antagonist messenger ribonucleic acids were assessed by reverse transcriptase-polymerase chain reaction, and chondrocyte lysates were analyzed by enzyme-linked immunosorbent assay for the respective proteins. Type I intracellular interleukin receptor antagonist transcripts were the only intracellular variant detected in osteoarthritis chondrocytes. In cartilage graded as advanced osteoarthritis both interleukin proteins in chondrocyte lysates decreased, correlating with decreased interleukin-1α and β messenger ribonucleic acids. Interleukin-1 receptor antagonist exceeded interleukin-1α in chondrocyte lysates by one order of magnitude except that in moderate osteoarthritis, antagonist was only two- to fourfold in excess. Interleukin-1α and interleukin-1β proteins were correlated closely in individual lysates, with interleukin-1β exceeding interleukin-1β by one order of magnitude. In moderately degenerated cartilage, intracellular antagonist may not be sufficiently abundant to block postulated intracellular functions of precursor interleukin-1α. Furthermore, if stored interleukin-1α, interleukin-1β, and interleukin receptor antagonist are released from chondrocytes, the localized antagonist would be insufficient to prevent signaling through cell surface receptors. Chondrocyte-derived interleukin-1α and interleukin-1β may locally overwhelm inhibition by interleukin receptor antagonist to promote the early degenerative changes in osteoarthritis.",
author = "Minako Murata and Carol Trahan and Junichi Hirahashi and Mankin, {Henry J.} and Towle, {Christine A.}",
year = "2003",
month = "4",
day = "1",
language = "English",
pages = "285--295",
journal = "Clinical Orthopaedics and Related Research",
issn = "0009-921X",
publisher = "Springer New York",
number = "409",

}

TY - JOUR

T1 - Intracellular interleukin-1 receptor antagonist in osteoarthritis chondrocytes

AU - Murata, Minako

AU - Trahan, Carol

AU - Hirahashi, Junichi

AU - Mankin, Henry J.

AU - Towle, Christine A.

PY - 2003/4/1

Y1 - 2003/4/1

N2 - The objective of the current study was to determine whether the balance of interleukin-1 and intracellular interleukin-1 receptor antagonist in chondrocytes in osteoarthritic human joints favors agonist action. Chondrocytes were isolated from cartilage specimens taken at the time of joint arthroplasty. Interleukin-1α, interleukin-1β, and intracellular interleukin-1 receptor antagonist messenger ribonucleic acids were assessed by reverse transcriptase-polymerase chain reaction, and chondrocyte lysates were analyzed by enzyme-linked immunosorbent assay for the respective proteins. Type I intracellular interleukin receptor antagonist transcripts were the only intracellular variant detected in osteoarthritis chondrocytes. In cartilage graded as advanced osteoarthritis both interleukin proteins in chondrocyte lysates decreased, correlating with decreased interleukin-1α and β messenger ribonucleic acids. Interleukin-1 receptor antagonist exceeded interleukin-1α in chondrocyte lysates by one order of magnitude except that in moderate osteoarthritis, antagonist was only two- to fourfold in excess. Interleukin-1α and interleukin-1β proteins were correlated closely in individual lysates, with interleukin-1β exceeding interleukin-1β by one order of magnitude. In moderately degenerated cartilage, intracellular antagonist may not be sufficiently abundant to block postulated intracellular functions of precursor interleukin-1α. Furthermore, if stored interleukin-1α, interleukin-1β, and interleukin receptor antagonist are released from chondrocytes, the localized antagonist would be insufficient to prevent signaling through cell surface receptors. Chondrocyte-derived interleukin-1α and interleukin-1β may locally overwhelm inhibition by interleukin receptor antagonist to promote the early degenerative changes in osteoarthritis.

AB - The objective of the current study was to determine whether the balance of interleukin-1 and intracellular interleukin-1 receptor antagonist in chondrocytes in osteoarthritic human joints favors agonist action. Chondrocytes were isolated from cartilage specimens taken at the time of joint arthroplasty. Interleukin-1α, interleukin-1β, and intracellular interleukin-1 receptor antagonist messenger ribonucleic acids were assessed by reverse transcriptase-polymerase chain reaction, and chondrocyte lysates were analyzed by enzyme-linked immunosorbent assay for the respective proteins. Type I intracellular interleukin receptor antagonist transcripts were the only intracellular variant detected in osteoarthritis chondrocytes. In cartilage graded as advanced osteoarthritis both interleukin proteins in chondrocyte lysates decreased, correlating with decreased interleukin-1α and β messenger ribonucleic acids. Interleukin-1 receptor antagonist exceeded interleukin-1α in chondrocyte lysates by one order of magnitude except that in moderate osteoarthritis, antagonist was only two- to fourfold in excess. Interleukin-1α and interleukin-1β proteins were correlated closely in individual lysates, with interleukin-1β exceeding interleukin-1β by one order of magnitude. In moderately degenerated cartilage, intracellular antagonist may not be sufficiently abundant to block postulated intracellular functions of precursor interleukin-1α. Furthermore, if stored interleukin-1α, interleukin-1β, and interleukin receptor antagonist are released from chondrocytes, the localized antagonist would be insufficient to prevent signaling through cell surface receptors. Chondrocyte-derived interleukin-1α and interleukin-1β may locally overwhelm inhibition by interleukin receptor antagonist to promote the early degenerative changes in osteoarthritis.

UR - http://www.scopus.com/inward/record.url?scp=0037388783&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037388783&partnerID=8YFLogxK

M3 - Article

C2 - 12671514

AN - SCOPUS:0037388783

SP - 285

EP - 295

JO - Clinical Orthopaedics and Related Research

JF - Clinical Orthopaedics and Related Research

SN - 0009-921X

IS - 409

ER -